학술논문
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Document Type
Article
Author
Le Gouill, Steven ; Beldi-Ferchiou, Asma ; Alcantara, Marion ; Cacheux, Victoria; Safar, Violaine; Burroni, Barbara; Guidez, Stéphanie; Gastinne, Thomas; Canioni, Danielle; Thieblemont, Catherine; Maisonneuve, Hervé; Bodet-Milin, Caroline; Houot, Roch; Oberic, Lucie; Bouabdallah, Krimo; Bescond, Charles; Damaj, Ghandi; Jaccard, Arnaud; Daguindau, Nicolas; Moreau, Anne; Tilly, Hervé; Ribrag, Vincent; Delfau-Larue, Marie-Hélène; Hermine, Olivier; Macintyre, Elizabeth
Source
In The Lancet Haematology November 2020 7(11):e798-e807
Subject
Language
ISSN
2352-3026